147 related articles for article (PubMed ID: 30866616)
1. Prospective Evaluation of Radiculitis following Bone Morphogenetic Protein-2 Use for Transforaminal Interbody Arthrodesis in Spine Surgery.
Sebastian AS; Wanderman NR; Currier BL; Pichelmann MA; Treder VM; Fogelson JL; Clarke MJ; Nassr AN
Asian Spine J; 2019 Aug; 13(4):544-555. PubMed ID: 30866616
[TBL] [Abstract][Full Text] [Related]
2. Comparison of transforaminal lumbar interbody fusion outcomes in patients receiving rhBMP-2 versus autograft.
Khan TR; Pearce KR; McAnany SJ; Peters CM; Gupta MC; Zebala LP
Spine J; 2018 Mar; 18(3):439-446. PubMed ID: 28822825
[TBL] [Abstract][Full Text] [Related]
3. A prospective, multi-institutional comparative effectiveness study of lumbar spine surgery in morbidly obese patients: does minimally invasive transforaminal lumbar interbody fusion result in superior outcomes?
Adogwa O; Carr K; Thompson P; Hoang K; Darlington T; Perez E; Fatemi P; Gottfried O; Cheng J; Isaacs RE
World Neurosurg; 2015 May; 83(5):860-6. PubMed ID: 25535070
[TBL] [Abstract][Full Text] [Related]
4. Bone Morphogenic Protein Is a Viable Adjunct for Fusion in Minimally Invasive Transforaminal Lumbar Interbody Fusion.
Siddiqui MM; Sta Ana AR; Yeo W; Yue WM
Asian Spine J; 2016 Dec; 10(6):1091-1099. PubMed ID: 27994786
[TBL] [Abstract][Full Text] [Related]
5. The minimally effective dose of bone morphogenetic protein in posterior lumbar interbody fusion: a systematic review and meta-analysis.
Lytle EJ; Lawless MH; Paik G; Tong D; Soo TM
Spine J; 2020 Aug; 20(8):1286-1304. PubMed ID: 32339767
[TBL] [Abstract][Full Text] [Related]
6. Biologics and Minimally Invasive Approach to TLIFs: What Is the Risk of Radiculitis?
Wang E; Stickley C; Manning J; Varlotta CG; Woo D; Ayres E; Abotsi E; Vasquez-Montes D; Fischer CR; Stieber J; Quirno M; Protopsaltis TS; Passias PG; Buckland AJ
Int J Spine Surg; 2020 Oct; 14(5):804-810. PubMed ID: 33046541
[TBL] [Abstract][Full Text] [Related]
7. Impact of Iliac Crest Bone Grafting on Postoperative Outcomes and Complication Rates Following Minimally Invasive Transforaminal Lumbar Interbody Fusion.
Haws BE; Khechen B; Patel DV; Yoo JS; Guntin JA; Cardinal KL; Ahn J; Singh K
Neurospine; 2019 Dec; 16(4):772-779. PubMed ID: 31284335
[TBL] [Abstract][Full Text] [Related]
8. Twelve-month results of a multicenter, blinded, pilot study of a novel peptide (B2A) in promoting lumbar spine fusion.
Sardar Z; Alexander D; Oxner W; du Plessis S; Yee A; Wai EK; Anderson DG; Jarzem P
J Neurosurg Spine; 2015 Apr; 22(4):358-66. PubMed ID: 25615629
[TBL] [Abstract][Full Text] [Related]
9. Contribution of recombinant human bone morphogenetic protein-2 to the rapid creation of interbody fusion when used in transforaminal lumbar interbody fusion: a preliminary report. Invited submission from the Joint Section Meeting on Disorders of the Spine and Peripheral Nerves, March 2004.
Mummaneni PV; Pan J; Haid RW; Rodts GE
J Neurosurg Spine; 2004 Jul; 1(1):19-23. PubMed ID: 15291015
[TBL] [Abstract][Full Text] [Related]
10. Complications associated with the use of the recombinant human bone morphogenetic proteins for posterior interbody fusions of the lumbar spine.
Chrastil J; Low JB; Whang PG; Patel AA
Spine (Phila Pa 1976); 2013 Jul; 38(16):E1020-7. PubMed ID: 23629484
[TBL] [Abstract][Full Text] [Related]
11. Exploratory meta-analysis on dose-related efficacy and morbidity of bone morphogenetic protein in spinal arthrodesis surgery.
Hofstetter CP; Hofer AS; Levi AD
J Neurosurg Spine; 2016 Mar; 24(3):457-75. PubMed ID: 26613283
[TBL] [Abstract][Full Text] [Related]
12. Impact of local steroid application in a minimally invasive transforaminal lumbar interbody fusion: results of a prospective, randomized, single-blind trial.
Haws BE; Khechen B; Patel DV; Bawa MS; Ahn J; Bohl DD; Mayo BC; Massel DH; Guntin JA; Cardinal KL; Singh K
J Neurosurg Spine; 2018 Nov; 30(2):222-227. PubMed ID: 30497132
[TBL] [Abstract][Full Text] [Related]
13. Posterolateral fusion (PLF) versus transforaminal lumbar interbody fusion (TLIF) for spondylolisthesis: a systematic review and meta-analysis.
Levin JM; Tanenbaum JE; Steinmetz MP; Mroz TE; Overley SC
Spine J; 2018 Jun; 18(6):1088-1098. PubMed ID: 29452283
[TBL] [Abstract][Full Text] [Related]
14. Clinical and radiographic outcomes of bilateral decompression via a unilateral approach with transforaminal lumbar interbody fusion for degenerative lumbar spondylolisthesis with stenosis.
Cheng X; Zhang K; Sun X; Zhao C; Li H; Ni B; Zhao J
Spine J; 2017 Aug; 17(8):1127-1133. PubMed ID: 28416439
[TBL] [Abstract][Full Text] [Related]
15. Does Bone Morphogenetic Protein Use Reduce Pseudarthrosis Rates in Single-Level Transforaminal Lumbar Interbody Fusion Surgeries?
Zhong J; Tareen J; Ashayeri K; Leon C; Balouch E; O'Malley N; Stickley C; Maglaras C; O'Connell B; Ayres E; Fischer C; Kim Y; Protopsaltis T; Buckland AJ
Int J Spine Surg; 2024 May; 18(2):207-216. PubMed ID: 38569928
[TBL] [Abstract][Full Text] [Related]
16. RhBMP-2-induced radiculitis in patients undergoing transforaminal lumbar interbody fusion: relationship to dose.
Villavicencio AT; Burneikiene S
Spine J; 2016 Oct; 16(10):1208-1213. PubMed ID: 27343729
[TBL] [Abstract][Full Text] [Related]
17. Results of lumbar spondylodeses using different bone grafting materials after transforaminal lumbar interbody fusion (TLIF).
vonderHoeh NH; Voelker A; Heyde CE
Eur Spine J; 2017 Nov; 26(11):2835-2842. PubMed ID: 28547573
[TBL] [Abstract][Full Text] [Related]
18. Do measures of surgical effectiveness at 1 year after lumbar spine surgery accurately predict 2-year outcomes?
Adogwa O; Elsamadicy AA; Han JL; Cheng J; Karikari I; Bagley CA
J Neurosurg Spine; 2016 Dec; 25(6):689-696. PubMed ID: 26722957
[TBL] [Abstract][Full Text] [Related]
19. Posterior lumbar interbody fusion using recombinant human bone morphogenetic protein type 2 with cylindrical interbody cages.
Haid RW; Branch CL; Alexander JT; Burkus JK
Spine J; 2004; 4(5):527-38; discussion 538-9. PubMed ID: 15363423
[TBL] [Abstract][Full Text] [Related]
20. Comparison of Preliminary clinical outcomes between percutaneous endoscopic and minimally invasive transforaminal lumbar interbody fusion for lumbar degenerative diseases in a tertiary hospital: Is percutaneous endoscopic procedure superior to MIS-TLIF? A prospective cohort study.
Ao S; Zheng W; Wu J; Tang Y; Zhang C; Zhou Y; Li C
Int J Surg; 2020 Apr; 76():136-143. PubMed ID: 32165279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
